MARKET

TEM

TEM

Tempus AI
NASDAQ
80.54
-3.90
-4.62%
After Hours: 80.42 -0.12 -0.15% 19:59 11/10 EST
OPEN
82.37
PREV CLOSE
84.44
HIGH
83.43
LOW
78.16
VOLUME
4.97M
TURNOVER
--
52 WEEK HIGH
89.09
52 WEEK LOW
40.77
MARKET CAP
14.69B
P/E (TTM)
-76.0601
1D
5D
1M
3M
1Y
5Y
1D
Tempus AI: Buy Maintained with Unchanged $95 Price Target on Data Platform and Growth Catalysts
TipRanks · 7h ago
Tempus’ Partner Blood Cancer United Launches Dare To Dream REALworld: AML, Patient-Centered Initiative Co-Founded With Rally Foundation For Childhood Cancer Research
Benzinga · 11h ago
Blood Cancer United Launches REALworld: AML to Accelerate New Treatments for Children with Blood Cancer
PR Newswire · 11h ago
Tempus AI Consensus Price Target Raised 16.31% to $89.36
NASDAQ · 22h ago
SOTERIA Precision Medicine Foundation Partners With Tempus To Provide Personalized, Data-Driven Cancer Treatment Insights, Genomic Sequencing To U.S. Military
Benzinga · 1d ago
CNH Industrial, Planet Labs, Ferguson Enterprises And Other Big Stocks Moving Higher On Monday
Benzinga · 1d ago
SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer
Barchart · 1d ago
tempus AI Inc Class A call volume above normal and directionally bullish
TipRanks · 1d ago
More
About TEM
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Webull offers Tempus AI Inc stock information, including NASDAQ: TEM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TEM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TEM stock methods without spending real money on the virtual paper trading platform.